Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: GlobalData
$250.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

RaQualia Pharma Inc Lowers Consolidated Full-year Forecast for FY 2013


Friday, 8 Nov 2013 01:30am EST 

RaQualia Pharma Inc announced that it has lowered the consolidated full-year forecast for revenue from JPY 1,014 million to JPY 223 million, operating profit (loss) from JPY (1,154 million) to JPY (2,309 million), ordinary profit (loss) from JPY (1,147 million) to JPY (2,052 million), net profit (loss) from JPY (1,151 million) to JPY (2,083 million) and earning (loss) per share from JPY (86.60) to JPY (155.46) for the fiscal year ending December 31, 2013. The Company lowered the consolidated full-year outlook due to increased expense on research and development. 

Company Quote

547.0
-8.0 -1.44%
22 Aug 2014